Reduced rCBV ratio in perfusion-weighted MR images predicts poor outcome after thrombolysis in acute ischemic stroke

European Neurology

Volumn 65, Issue 5, 2011, Pages 257-263

  Park, Hyang I ^a   Cha, Jae Kwan ^a   Kang, Myung Jin ^a   Kim, Dae Hyun ^a   Yoo, Nam Tae ^a   Choi, Jae Hyung ^a   Huh, Jae Taeck ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Magnetic resonance imaging; Perfusion; Stroke; t PA

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD VOLUME; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEEDLE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROGNOSIS; RECANALIZATION;

AGED; ANALYSIS OF VARIANCE; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79953264942     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000324727     Document Type: Article

References (27)

1. The National Institute of Neurologic Disorder and Stroke rt-PA Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
2. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al, American Heart Association/American Stroke Association Stroke Council (AHA/ASASC): Guidelines for the early management of adults with ischemic stroke: A guideline from the AHA/ ASASC, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711. (Pubitemid 46691097)
3. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM: Prediction of stroke outcome with echoplanar perfusion- and diffusionweighted MRI. Neurology 1998; 51: 418-426. (Pubitemid 28406316)
4. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Modder U, et al: Diffusion- and perfusion-weighted MRI: The DWI/PWI mismatch region in acute stroke. Stroke 1999; 30: 1591-1597. (Pubitemid 29379608)
5. Kohrmann M, Juttler E, Huttner H, Nowe T, Schellinger P: Acute stroke imaging for thrombolytic therapy. An update. Cerebrovasc Dis 2007; 24:161-169. (Pubitemid 47295580)
6. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: A metaanalysis. Stroke 2007; 38: 967-973. (Pubitemid 46568460)
7. Sorensen AG, Copen WA, Ostergaard L, Buonanno FS, Gonzalez RG, Rordorf G, et al: Simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and tissue mean transit time in patients presenting with hyperacute stroke. Radiology 1999; 210: 519-527. (Pubitemid 29055324)
8. Liu Y, Karonen JO, Vanninen RL, Nuutinen J, Koskela A, Soimakallio S, et al: Acute ischemic stroke: Predictive value of 2D phasecontrast MR angiography - serial study with combined diffusion and perfusion MR imaging. Radiology 2004; 231: 517-527. (Pubitemid 38552913)
9. Lee SY, Cha JK, Kang MJ. Regional cerebral blood volume ratio on perfusion MRI on the growth of infarct size in acute ischemic stroke. Eur Neurol 2009; 62: 281-286.
10. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, et al: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73. (Pubitemid 40054177)
11. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study investigators. Lancet 1998; 352: 1245-1251. (Pubitemid 28470336)
12. Sobesky J, Weber OZ, Lehnhardt FG, Hesselmann V, Thiel A, Dohman C, et al: Which time to peak threshold best identifies penumbral flow? A comparison of perfusionweighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004; 35: 2843-2847. (Pubitemid 39565181)
13. Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezéne Y, Philippeau F, et al: Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci 2004; 225: 3-9. (Pubitemid 39311703)
14. Schellinger PD, Thomalla G, Fiehler J, Kohmann M, Molina CA, Neumann-Haefelin T, et al: MRI-based and CT-based thrombolytic therapy in acute stroke in within and beyond established time windows: An analysis of 1,210 patients. Stroke 2007; 38: 2640-2645. (Pubitemid 47493997)
15. Kucinski T, Naumann D, Knab R, Schoder V, Wegener S, Fiehler J, et al: Tissue at risk is overestimated in perfusion-weighted imaging: MR imaging in acute stroke patients without vessel recanalization. AJNR Am J Neuroradiol 2005; 26: 815-819. (Pubitemid 43079773)
16. Kane I, Sandercock P, Wardlaw J: Magnet - ic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: A systemic review of the evidence of debate. J Neurol Neurosurg Psychiatry 2007; 78: 485-491.
17. Miles KA. Brain perfusion: Computed tomography applications. Neuroradiology 2004; 46: 194-200.
18. Kloska SP, Dittrich R, Fischer T, Nabavi DG, Fischbach R, Seidensticker P, et al: Perfusion CT in acute stroke: Prediction of vessel recanalization and clinical outcome in intravenous thrombolytic therapy. Eur Radiol 2007; 17: 2491-2498.
19. Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B et al, UCLA Collateral Investigators: Impact of collateral flow on tissue fate in acute ischemic stroke. J Neurol Neurosurg Psychiatry 2008; 79: 625-629. (Pubitemid 351829431)
20. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A: Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992; 42: 289-298.
21. Bhatt A, Vora NA, Thomas AJ, Majid A, Kassab M, Hammer MD, et al: Lower pretreatment cerebral blood volume affects hemorrhagic risks after intra-arterial revascularization in acute stroke. Neurosurgery 2008; 63: 874-878.
22. Sanak D, Nosal V, Horak D, Bartkova A, Zelenak K, Herzig R, et al: Impact of diffusion- weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology 2006; 48: 632-639. (Pubitemid 44355773)
23. Kimura K, Iguchi Y, Shibazaki K, Terasawa Y, Inoue T, Uemura J, et al: Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke. Stroke 2008; 38: 2388-2391.
24. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, et al: Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke 2008; 39: 2257-2263.
25. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, González RG: MRI-based selection for intra-arterial stroke therapy: Value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009; 40: 2046-2054.
26. Mitsias PD, Jacobs MA, Hammoud R, Pasnoor M, Santhakumar S, Papamitsakis NI, et al: Multi-parametric MRI ischemic lesion analysis: Correlation with the clinical neurological deficit and single-parameter MRI techniques. Stroke 2002; 33: 2839-2844. (Pubitemid 35462853)
27. Shih LC, Saver JL, Alger JR, Starkman S, Leary MC, Vinuela F, et al: Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003; 34: 1425-1430. (Pubitemid 36693511)